跳至主要内容
临床试验/NCT01766284
NCT01766284已完成不适用

Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix (PUSHOCTII)

Preventive Oncology International, Inc.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
To determine the accuracy of VIA plus Niris 1300e OCT enhanced gynecologic examination.

研究概览

简要总结

Optical Coherence Tomography (OCT) is a technology using harmless near infra-red light scatter to produce an image. Prior studies with OCT have demonstrated that OCT of the uterine cervix can differentiate between grades of pre-invasive and invasive cervical disease and cancer. This study will evaluate the ability of the NIRIS 1300e imaging (OCT) system to detect pre-invasive cervical disease and cervical cancer.

详细描述

B. Specific Aims

  1. Primary. To determine the sensitivity, specificity, positive and negative predictive values for Niris 1300e OCT enhanced gynecologic examination (VIA-OCT vs.colposcopy-biopsy) for the detection of lesions equal or greater than cervical intraepithelial neoplasia II (CIN II) and cancer in a "real time" clinical evaluation.
  2. Secondary. To examine the ease of use of Niris 1300e OCT in a real time clinical setting in order to assess its potential application during a "see and treat" or "single episode of care" clinic visit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Female subjects > 18 years of age
  • •Subject must voluntarily sign a Patient Informed Consent Form specific to the study.
  • •Subject must be physically and mentally willing to comply with all study requirements, especially conduct of a colposcopy exam.
  • •Participant must be attending the Center for Cervical Diagnosis.

排除标准

  • •Based on clinical history, physical exam and patient presentation, the subject is unable to provide adequate informed consent and/or comply with the study requirements.
  • •Subject is a prisoner.
  • •Subject is pregnant.
  • •Subject has had a hysterectomy
  • •Subject has received prior pelvic radiotherapy.

研究组 & 干预措施

Niris 1300e OCT imaging

Experimental

OCT imaging of the cervix using Niris 1300e will include computer aided calculations for epithelial brightness.

干预措施: NIRIS 1300e (Device)

结局指标

主要结局

To determine the accuracy of VIA plus Niris 1300e OCT enhanced gynecologic examination.

时间窗: Study will be completed over a 4 day period with OCT and brightness determination as each patient is seen. During the next 4 months, we will conduct blinded reviews of the images to determine new sets of brightness numbers.

次要结局

  • To compare OCT image (Niris 1300e) technology directly to colposcopy with biopsy for the detection of lesions equal or greater than cervical intraepithelial neoplasia II (CIN II) and cancer in a "real time" clinical evaluation.(Study will be completed over a 4 day period with OCT and brightness determination as each patient is seen. During the next 4 months we will conduct blinded reviews of the images to determine new sets of brightness numbers.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验